Showing results (2281-2290 of 3,353) with videos related to
Sort By:
Pageof 336
Pharmacoeconomics|March 31, 2018
Paclitaxel as Albumin-Bound Nanoparticles with Gemcitabine for Untreated Metastatic Pancreatic Cancer: An Evidence Review Group Perspective of a NICE Single Technology AppraisalAngela Stainthorpe, Janette Greenhalgh, Adrian Bagust, et al.Pharmacoeconomics|July 6, 2014
Hospital-based health technology assessment: developments to dateMarie-Pierre GagnonPharmacoeconomics|November 5, 2020
Budget Impact of Oral Semaglutide Intensification versus Sitagliptin among US Patients with Type 2 Diabetes Mellitus Uncontrolled with MetforminElizabeth Wehler, Dominik Lautsch, Stacey Kowal, et al.Pharmacoeconomics|November 4, 2020
Lenalidomide with Rituximab for Previously Treated Follicular Lymphoma and Marginal Zone Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology AppraisalWillem J A Witlox, Sabine E Grimm, Rob Riemsma, et al.Pharmacoeconomics|October 31, 2020
Dealing with Bad Risk in Cost-Effectiveness Analysis: The Cost-Effectiveness Risk-Aversion CurvePedram SendiPharmacoeconomics|April 9, 2022
A Comparison of Methods for Identifying Informal Carers: Self-Declaration Versus a Time DiarySean Urwin, Yiu-Shing Lau, Gunn Grande, et al.Pharmacoeconomics|December 23, 2015
Rivaroxaban for Preventing Atherothrombotic Events in People with Acute Coronary Syndrome and Elevated Cardiac Biomarkers: An Evidence Review Group Perspective of a NICE Single Technology AppraisalAbdullah Pandor, Daniel Pollard, Tim Chico, et al.Pharmacoeconomics|January 29, 2016
The Clinical and Cost Effectiveness of Ustekinumab for the Treatment of Psoriatic Arthritis: A Critique of the EvidenceJoanne O'Connor, Stephen Rice, Alison Smith, et al.Pharmacoeconomics|January 22, 2016
EQ-5D Utilities in Chronic Spontaneous/Idiopathic UrticariaEmma Hawe, Doreen McBride, Maria-Magdalena Balp, et al.Pharmacoeconomics|October 27, 2015
The Irish Cost-Effectiveness Threshold: Does it Support Rational Rationing or Might it Lead to Unintended Harm to Ireland's Health System?James F O'Mahony, Diarmuid CoughlanPageof 336